Related references
Note: Only part of the references are listed.
Editorial Material
Dermatology
The EMEA suspends approval of Raptiva for psoriasis
J. C. Prinz
HAUTARZT (2009)
Editorial Material
Dermatology
Comments of the DDG und the BVDD to EMEA-Recommendation on the approval of Raptiva® (Efalizumab)
Thomas Luger et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Article
Dermatology
Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study
Alan Menter et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2007)
Share Paper
